In this piece, I evaluated two pharma stocks, Relay Therapeutics, Inc. (RLAY) and Perrigo Company plc (PRGO), to determine which holds better upside potential. Based on the fundamental comparison of these stocks, I believe PRGO is the better buy for the reasons explained throughout this article.
The pharmaceutical industry is well-poised for significant profitability, thanks to sustained demand and spending for medicines amid a rapidly aging population worldwide, the growing prevalence of chronic diseases, and new innovative drugs to treat rare and specialty diseases. Last year, nearly 771 million people aged 65+ years worldwide, almost 10% of the global population.
